Abstract: Disclosed herein are materials, articles of manufacture, and methods for decreasing, mitigating, removing or precluding formation of an amount of a nitrosating agent and/or an N-nitroso compound, including an N-nitrosamine, in an enclosure of a pharmaceutical drug package to inhibit a potential adverse health effect on a patient associated with the nitrosating agent or N-nitroso compound. The package contains an active agent and a pharmaceutical dosage form in an enclosure of the package. The active agent, consisting essentially of sodium bicarbonate in a granular, particulate or powdered form, is effective to decrease, mitigate, remove or preclude the formation of an amount of the nitrosating agent and/or N-nitroso compound in the enclosure and/or in the pharmaceutical dosage form. Also provided are drug delivery systems including a blister pack configured to house multiple pharmaceutical dosage forms, the blister pack including an active agent as discussed above.

Abstract: Disclosed herein are materials, articles of manufacture, and methods for decreasing, mitigating, removing or precluding formation of an amount of a nitrosating agent and/or an N-nitroso compound, including an N-nitrosamine, in an enclosure of a pharmaceutical drug package to inhibit a potential adverse health effect on a patient associated with the nitrosating agent or N-nitroso compound. The package contains an active agent and a pharmaceutical dosage form in an enclosure of the package. The active agent, consisting essentially of sodium bicarbonate in a granular, particulate or powdered form, is effective to decrease, mitigate, remove or preclude the formation of an amount of the nitrosating agent and/or N-nitroso compound in the enclosure and/or in the pharmaceutical dosage form. Also provided are drug delivery systems including a blister pack configured to house multiple pharmaceutical dosage forms, the blister pack including an active agent as discussed above.

Abstract: Disclosed herein are materials, articles of manufacture, and methods for reducing, mitigating, or precluding formation of and/or amount of a nitrosating agent and/or an N-nitroso compound, including an N-nitrosamine, from a packaging containing an active agent and a pharmaceutical dosage form in an enclosure, wherein the active agent is effective to reduce mitigate or preclude the formation and/or amount of a nitrosating agent and/or N-nitroso compound in the enclosure and/or in the pharmaceutical dosage form. Provided are drug delivery systems comprising a blister pack configured to house multiple pharmaceutical dosage forms, the blister pack comprising an active ingredient that is effective to reduce, mitigate or preclude the formation and/or amount of a nitrosating agent and/or N-nitroso compound in an enclosure of the blister pack and/or in the pharmaceutical dosage form.

Abstract: This invention relates generally to zeolites and polymer compositions with zeolites having enhanced adsorption capacity for adsorption of water, ammonia and other similar compounds. The invention is directed particularly to aluminosilicate zeolites, and methods for preparing zeolite entrained polymer compositions having enhanced water adsorption properties. This invention relates also to improved packaging materials with enhanced water adsorption properties incorporating the polymer compositions containing zeolites.

Abstract: This invention relates generally to zeolites and polymer compositions with zeolites having enhanced adsorption capacity for adsorption of water, ammonia and other similar compounds. The invention is directed particularly to aluminosilicate zeolites, and methods for preparing zeolite entrained polymer compositions having enhanced water adsorption properties. This invention relates also to improved packaging materials with enhanced water adsorption properties incorporating the polymer compositions containing zeolites.

Abstract: A process for preparing a nanometric zeolite Y of FAU structural type with a crystal size of less than 100 nm and an A/B ratio of greater than 2, by mixing, in aqueous medium, of at least one source AO2 of at least one tetravalent element A chosen from silicon, germanium and titanium, of at least one source BOb of at least one trivalent element B chosen from aluminum, boron, iron, indium and gallium, of at least one source C2/mO of an alkali metal or alkaline-earth metal C chosen from lithium, sodium, potassium, calcium and magnesium, where source C2/mO also includes at least one source of hydroxide ions, to obtain a gel, maturation and hydrothermal treatment of the gel.

Abstract: A process for preparing a nanometric zeolite Y of FAU structural type with a crystal size of less than 100 nm and an A/B ratio of greater than 2, by mixing, in aqueous medium, of at least one source AO2 of at least one tetravalent element A chosen from silicon, germanium and titanium, of at least one source BOb of at least one trivalent element B chosen from aluminum, boron, iron, indium and gallium, of at least one source C2/mO of an alkali metal or alkaline-earth metal C chosen from lithium, sodium, potassium, calcium and magnesium, where source C2/mO also includes at least one source of hydroxide ions, to obtain a gel, maturation and hydrothermal treatment of the gel.